Surgical Treatment for Primary Hyperparathyroidism in Hong Kong: Changes in Clinical Pattern over 3 Decades

Archives of Surgery

Volumn 139, Issue 1, 2004, Pages 77-82

  Lo, Chung Yau ^a   Chan, Wai Fan ^a   Kung, Annie W C ^a   Lam, King Yin ^a   Tam, Sidney C F ^a   Lam, Karen S L ^a   Grant, Clive ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; PARATHYROID HORMONE;

ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HONG KONG; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGE DISTRIBUTION; COHORT STUDIES; FEMALE; HONG KONG; HUMANS; HYPERPARATHYROIDISM; INCIDENCE; MALE; MIDDLE AGED; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 0346998112     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.1.77     Document Type: Article

References (23)

1. Bilezikian JP, Meng X, Shi Y, Silverberg SJ. Primary hyperparathyroidism in women: a tale of two cities - New York and Beijing. Int J Fertil Womens Med. 2000;45: 158-165.
2. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980;1:1317-1320.
3. Silverberg SJ, Bilezikian JP, Bone HG, Talpos GB, Horwitz MJ, Stewart AF. Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab. 1999;84:2275-2285.
4. Shek CC, Natkunam A, Tsang V, Cockram CS, Swaminathan R. Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong. Q J Med. 1990;77:1277-1285.
5. Cheung PS, Boey JH, Wang CC, Ma JT, Lam KS, Yeung RT. Primary hyperparathyroidism: its clinical pattern and results of surgical treatment in Hong Kong Chinese. Surgery. 1988;103:558-562.
6. Ingemansson SG, Hugosson CH, Woodhouse NJ. Vitamin D deficiency and hyperparathyroidism with severe bone disease. World J Surg. 1988;12:517-521.
7. Agarwal G, Mishra SK, Kar DK, et al. Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy. Surgery. 2002;132:1075-1083.
8. Mishra SK, Agarwal G, Kar DK, Gupta SK, Mithal A, Rastad J. Unique clinical characteristics of primary hyperparathyroidism in india. Br J Surg. 2001;88:708-714.
9. Meng X, Xing X, Liu S. The diagnosis of primary hyperparathyroidism - analysis of 134 cases [in Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1994;16:13-19.
10. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 1989;24:148-154.
11. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 2002;17(suppl 2):N18-N23.
12. Lundgren E, Rastad J, Thrufjell E, Akerstrom G, Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997;121:287-294.
13. Silverberg SJ, Bilezikian JP. Primary hyperparathyroidism: still evolving? J Bone Miner Res. 1997;12:856-862.
14. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302:189-193.
15. Melton LJ III. The epidemiology of primary hyperparathyroidism in North America. J Bone Miner Res. 2002;17(suppl 2):N12-N17.
16. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ III. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 1997;126:433-440.
17. Innes A, Catto GR, Reid I, Matheson NA. The infrequency of primary hyperparathyroidism in north-east Scotland. J R Coll Surg Edinb. 1987;32:263-266.
18. Mollerup CL, Bollerslev J, Blichert-Toft M. Primary hyperparathyroidism: incidence and clinical and biochemical characteristics: a demographic study. Eur J Surg. 1994;160:485-489.
19. Sosa JA, Powe NR, Levine MA, Udelsman R, Zeiger MA. Profile of a clinical practice: thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons. J Clin Endocrinol Metab. 1998;83:2658-2665.
20. Sackett WR, Barraclough B, Reeve TS, Delbridge LW. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg. 2002;137:1055-1059.
21. Toft AD. Surgery for primary hyperparathyroidism - sooner rather than later. Lancet. 2000;355:1478-1479.
22. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249-1255.
23. Sywak MS, Robinson BG, Clifton-Bligh P, et al. Increase in presentations and procedure rates for hyperparathyroidism in Northern Sydney and New South Wales. Med J Aust. 2002;177:246-249.